TCG Crossover Management, LLC
PALO ALTO, CA · CIK 1839948 · 13F filing filed 2025-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyPalo Alto, CA
$875.5m
reported value
+19.4% vs Q1 2025
38positions
56.3%in top 10
5 new
1 added
3 reduced
5 sold out
vs Q1 2025
Holdings, Q2 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| CG ONCOLOGY INC CGON | $95.4m10.90% | Unchanged |
| TANGO THERAPEUTICS INC TNGX | $55.0m6.28% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $50.0m5.71% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $49.4m5.64% | Unchanged |
| CIDARA THERAPEUTICS INC CDTX | $49.0m5.60% | Unchanged |
| ABIVAX SA ABVX | $46.3m5.29% | Unchanged |
| AMYLYX PHARMACEUTICALS INC AMLX | $38.1m4.35% | Unchanged |
| CENTESSA PHARMACEUTICALS PLC SPONSORED ADS | $38.0m4.34% | Unchanged |
| FULCRUM THERAPEUTICS INC FULC | $36.1m4.13% | Unchanged |
| DYNE THERAPEUTICS INC DYN | $35.9m4.10% | Added +1.1m |
| EYEPOINT PHARMACEUTICALS INC EYPT | $33.6m3.84% | Unchanged |
| UPSTREAM BIO INC UPB | $30.8m3.51% | Unchanged |
| SAVARA INC SVRA | $28.2m3.22% | Unchanged |
| DIANTHUS THERAPEUTICS INC DNTH | $28.0m3.20% | Unchanged |
| TYRA BIOSCIENCES INC TYRA | $27.7m3.17% | Unchanged |
| DISC MEDICINE INC IRON | $24.6m2.81% | Unchanged |
| TOURMALINE BIO INC TRML | $23.6m2.70% | Unchanged |
| AGIOS PHARMACEUTICALS INC AGIO | $23.2m2.65% | New |
| STRUCTURE THERAPEUTICS INC GPCR | $22.0m2.52% | Unchanged |
| XENCOR INC XNCR | $19.3m2.20% | Unchanged |
| SILENCE THERAPEUTICS PLC SLN | $17.6m2.01% | Unchanged |
| SOLENO THERAPEUTICS INC SLNO | $15.6m1.78% | Reduced -88.8k |
| ASTRIA THERAPEUTICS INC CATB | $14.8m1.69% | Unchanged |
| RAPT THERAPEUTICS INC RAPT | $13.1m1.50% | New |
| THIRD HARMONIC BIO INC COM | $10.4m1.19% | Reduced -590.0k |
| ENLIVEN THERAPEUTICS INC ELVN | $10.0m1.14% | New |
| MBX BIOSCIENCES INC MBX | $7.4m0.85% | Unchanged |
| NEKTAR THERAPEUTICS NKTR | $6.9m0.79% | New |
| VISTAGEN THERAPEUTICS INC VTGN | $5.4m0.61% | Unchanged |
| KODIAK SCIENCES INC KOD | $4.3m0.49% | Unchanged |
| KURA ONCOLOGY INC KURA | $4.2m0.48% | Reduced -688.5k |
| ENTRADA THERAPEUTICS INC TRDA | $3.9m0.45% | Unchanged |
| ADVERUM BIOTECHNOLOGIES INC ADVM | $3.9m0.44% | Unchanged |
| AVALO THERAPEUTICS INC AVTX | $2.4m0.28% | Unchanged |
| VENTYX BIOSCIENCES INC VTYX | $676.7k0.08% | Unchanged |
| JADE BIOSCIENCES INC JBIO | $639.6k0.07% | New |
| CABALETTA BIO INC CABA | $131.9k0.02% | Unchanged |
| KEROS THERAPEUTICS INC KROS | $00.00% | Unchanged |
Sold out since Q1 2025
| Security | Value then |
|---|---|
| MINERALYS THERAPEUTICS INC MLYS | $39.2m2.5m shares |
| RAPT THERAPEUTICS INC | $16.0m13.1m shares |
| COMPASS PATHWAYS PLC CMPS | $11.0m3.9m shares |
| AEROVATE THERAPEUTICS INC | $5.6m2.2m shares |
| NEKTAR THERAPEUTICS | $2.7m4.0m shares |